array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(16) "COLORCON LIMITED"
["slug"]=>
string(25) "1f2f0-gb-colorcon-limited"
["logo"]=>
NULL
["description"]=>
string(912) "Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations.
Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base.
Follow us on Twitter @Colorcon"
["address_street"]=>
string(14) "Flagship House"
["address_place"]=>
string(8) "DARTFORD"
["address_region"]=>
NULL
["founding_date"]=>
NULL
["website_domain"]=>
NULL
["website_url"]=>
NULL
["industry_codes"]=>
array(1) {
[0]=>
string(27) "Pharmaceutical Preparations"
}
["employee_count"]=>
int(264)
["article_count"]=>
int(96)
}
["articles"]=>
array(2) {
[0]=>
array(7) {
["title_en"]=>
string(17) "Colorcon Ventures"
["snippet_en"]=>
string(153) "Colorcon Ventures . Richard Hayhurst . Richard Hayhurst Associates, Ltd. +44 7711-821527 . richard@rhapr.eu i2O Therapeutics . Lauren Arnold . MacDougall"
["url"]=>
string(51) "https://www.colorcon.com/news/download/3186/4821/34"
["image_url"]=>
NULL
["source"]=>
string(12) "colorcon.com"
["publication_date"]=>
string(10) "2020-12-03"
["categories"]=>
array(1) {
[0]=>
string(22) "EU Political Evolution"
}
}
[1]=>
array(7) {
["title_en"]=>
string(108) "StarCap 1500® Co-Processed Starch Excipient Receives Pharmaceutical Precedence of Use in the European Union"
["snippet_en"]=>
string(158) "/PRNewswire/ -- Colorcon Inc., announces StarCap 1500® a co-processed excipient has recently gained precedence of use within the European Union (EU) in an..."
["url"]=>
string(162) "https://www.prnewswire.com/news-releases/starcap-1500-co-processed-starch-excipient-receives-pharmaceutical-precedence-of-use-in-the-european-union-149484765.html"
["image_url"]=>
NULL
["source"]=>
string(14) "prnewswire.com"
["publication_date"]=>
string(10) "2012-04-30"
["categories"]=>
array(1) {
[0]=>
string(22) "EU Political Evolution"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(14)
}
[1]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(11)
}
[2]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(9)
}
[3]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(8)
}
[4]=>
array(2) {
["name"]=>
string(5) "R & D"
["count"]=>
int(4)
}
[5]=>
array(2) {
["name"]=>
string(37) "Product Design & Lifecycle Management"
["count"]=>
int(4)
}
[6]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(3)
}
[7]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(2)
}
[8]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(2)
}
[9]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(2)
}
[10]=>
array(2) {
["name"]=>
string(22) "EU Political Evolution"
["count"]=>
int(2)
}
[11]=>
array(2) {
["name"]=>
string(5) "Event"
["count"]=>
int(2)
}
[12]=>
array(2) {
["name"]=>
string(11) "Competition"
["count"]=>
int(1)
}
[13]=>
array(2) {
["name"]=>
string(20) "Contract negotiation"
["count"]=>
int(1)
}
[14]=>
array(2) {
["name"]=>
string(10) "Cybercrime"
["count"]=>
int(1)
}
[15]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(1)
}
[16]=>
array(2) {
["name"]=>
string(41) "E-commerce and Technological Developments"
["count"]=>
int(1)
}
[17]=>
array(2) {
["name"]=>
string(19) "Economic Conditions"
["count"]=>
int(1)
}
[18]=>
array(2) {
["name"]=>
string(23) "Supply Chain Management"
["count"]=>
int(1)
}
[19]=>
array(2) {
["name"]=>
string(15) "Supply & Demand"
["count"]=>
int(1)
}
[20]=>
array(2) {
["name"]=>
string(17) "Business Disputes"
["count"]=>
int(1)
}
[21]=>
array(2) {
["name"]=>
string(19) "Foreign Development"
["count"]=>
int(1)
}
[22]=>
array(2) {
["name"]=>
string(7) "Funding"
["count"]=>
int(1)
}
[23]=>
array(2) {
["name"]=>
string(20) "Business Development"
["count"]=>
int(1)
}
[24]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(1)
}
[25]=>
array(2) {
["name"]=>
string(22) "Business Certification"
["count"]=>
int(1)
}
[26]=>
array(2) {
["name"]=>
string(33) "Materials Sourcing and Efficiency"
["count"]=>
int(1)
}
[27]=>
array(2) {
["name"]=>
string(6) "Merger"
["count"]=>
int(1)
}
[28]=>
array(2) {
["name"]=>
string(10) "New Market"
["count"]=>
int(1)
}
[29]=>
array(2) {
["name"]=>
string(7) "Opening"
["count"]=>
int(1)
}
}
}
1f2f0-gb-colorcon-limited
COLORCON LIMITED
COLORCON LIMITED
Location
Founded
Website
Articles
96 Articles
Category
Pharmaceutical Preparations
Description
Colorcon® is a world leader in the development, supply and technical support of formulated film coating systems, modified release technologies, and functional excipients for the pharmaceutical and nutritional industries. Our best-in-class products and technologies are complemented by our extensive formulation experience, application data and value-added services to support all phases of solid oral dose design, development and manufacture. Our focus on market issues and technology development has earned Colorcon an international reputation as a pharmaceutical supplier of choice. That reputation is based on superior product quality, unparalleled technical support, extensive regulatory assistance and reliable supply from multiple locations.
Colorcon has 22 technical service laboratories globally and more than 1300 employees exclusively dedicated to its customer base.
Follow us on Twitter @Colorcon
/PRNewswire/ -- Colorcon Inc., announces StarCap 1500® a co-processed excipient has recently gained precedence of use within the European Union (EU) in an...
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
